Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 1
1976 2
1977 4
1978 1
1979 1
1985 1
1987 1
1989 1
1994 2
1995 2
1996 2
1997 2
1998 9
1999 3
2000 7
2001 5
2002 4
2003 4
2004 1
2010 2
2012 1
2013 1
2016 1
2018 2
2021 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
[Retterstøl and colleagues respond].
Retterstøl K, Munkhaugen J, Igul CB, Grimsmo J, Kask A, Schirmer H, Semb AG, Solberg EE. Retterstøl K, et al. Among authors: kask a. Tidsskr Nor Laegeforen. 2021 Mar 8;141(4). doi: 10.4045/tidsskr.21.0122. Print 2021 Mar 9. Tidsskr Nor Laegeforen. 2021. PMID: 33685109 Free article. Norwegian. No abstract available.
[PCSK9 inhibitors on reimbursable prescription: who is eligible?].
Semb AG, Vesterbekkmo EK, Retterstøl K, Atar D, Solberg EE, Schirmer H, Løchen ML, Kask A, Grimsmo J, Ingul CB, Munkhaugen J. Semb AG, et al. Among authors: kask a. Tidsskr Nor Laegeforen. 2023 May 29;143(8). doi: 10.4045/tidsskr.23.0191. Print 2023 May 30. Tidsskr Nor Laegeforen. 2023. PMID: 37254976 Free article. Norwegian. No abstract available.
Transgenic rat model of Huntington's disease.
von Hörsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, Grasshoff U, Bauer I, Vieira-Saecker AM, Paul M, Jones L, Lindenberg KS, Landwehrmeyer B, Bauer A, Li XJ, Riess O. von Hörsten S, et al. Among authors: kask a. Hum Mol Genet. 2003 Mar 15;12(6):617-24. doi: 10.1093/hmg/ddg075. Hum Mol Genet. 2003. PMID: 12620967
[Lower treatment goals for LDL cholesterol should be introduced].
Retterstøl K, Munkhaugen J, Ingul CB, Grimsmo J, Kask A, Schirmer H, Semb AG, Solberg EE. Retterstøl K, et al. Among authors: kask a. Tidsskr Nor Laegeforen. 2021 Jan 22;141(2). doi: 10.4045/tidsskr.20.0761. Print 2021 Feb 2. Tidsskr Nor Laegeforen. 2021. PMID: 33528123 Free article. Norwegian. No abstract available.
Physostigmine treatment of progressive supranuclear palsy.
Litvan I, Gomez C, Atack JR, Gillespie M, Kask AM, Mouradian MM, Chase TN. Litvan I, et al. Among authors: kask am. Ann Neurol. 1989 Sep;26(3):404-7. doi: 10.1002/ana.410260318. Ann Neurol. 1989. PMID: 2802540 Clinical Trial.
[Correction: Lower treatment goals for LDL cholesterol should be introduced].
Retterstøl K, Munkhaugen J, Ingul CB, Grimsmo J, Kask A, Schirmer H, Semb AG, Solberg EE. Retterstøl K, et al. Among authors: kask a. Tidsskr Nor Laegeforen. 2021 Feb 22;141(4). doi: 10.4045/tidsskr.21.0096. Print 2021 Mar 9. Tidsskr Nor Laegeforen. 2021. PMID: 33685112 Free article. Norwegian. No abstract available.
69 results